For the first time, after decades of testing and tweaking, researchers have developed – and the FDA has approved – a RSV vaccine for this sometimes-deadly virus. Is it safe, and who should get it?
– RSV is a respiratory disease most people think is only dangerous for babies but it actually can be life-threatening for older people as well. Now, for the first time, after decades of testing and tweaking, researchers have developed – and the FDA has approved – a vaccine for this sometimes-deadly virus. Is it safe, and who should get it?
Now, for the first time, a vaccine is approved for adults 60 and older. But what is RSV? RSV stands for respiratory syncytial virus. It mimics the common cold but can turn into pneumonia. Infectious disease experts say babies, older people and anyone with a compromised immune system is at risk. To date, two vaccines have FDA-approval – the first made by GSK – the brand name is Arexvy, the second was created by Pfizer. In clinical trials, the new RSV vaccine showed that the once-a-year shot lowered the risk of symptoms by 83 percent and severe illness by 94 percent.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The Health Promotion Hideaway; a UArizona mental health resource for studentsThe University of Arizona Health Promotion Hideaway is offering a safe, calming space for students to help them manage stresses of the college experience.
Read more »
Flu, Covid and RSV: Preventing another 'Tripledemic'As summer nears its end and the school year begins, it's a good time to think about getting those fall vaccinations against viruses that circulate in colder weather. A so-called 'Tripledemic' of Covid-19, the flu and RSV spread throughout the country last winter. To prevent a repeat, health officials are encouraging everyone to get vaccinated against Covid-19 and the flu, and now there are new protections against RSV. CBS News Bay Area's Ryan Yamamoto asks Dr. Jorge Salinas, infectious diseases specialist at Stanford Health Care, about the recommended vaccines
Read more »
FDA approves 1st maternal RSV vaccine to help protect infantsThe U.S. Food and Drug Administration has approved the first maternal vaccine intended to help protect newborns against respiratory syncytial virus (RSV).
Read more »
US FDA approves Pfizer's maternal RSV vaccine to protect infantsThe U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.
Read more »
FDA approves first RSV vaccine for pregnancy to protect newbornsExpectant parents could soon have another new option this fall to protect their newborns from RSV, the most common cause of hospitalization in American infants.
Read more »